Simon Cockell

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Dominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol et al. · Nature · 2021 · 1.2K citations · Full text

Life Sciences, Immunology, Oncology +17

Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆

Quentin M. Anstee, Rebecca Darlay, Simon Cockell et al. · Journal of Hepatology · 2020 · 514 citations · Full text

Medicine, Genetics, Molecular Genetics +13

Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

Olivier Govaere, Simon Cockell, Dina Tiniakos et al. · Science Translational Medicine · 2020 · 454 citations · Full text

Life Sciences, Molecular Biology, Molecular Medicine +16

A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren’s Syndrome

Katherine James, Shereen Al-Ali, Jessica Tarn et al. · PLoS ONE · 2015 · 178 citations · Full text

Life Sciences, Bioinformatics, Immunology +17

Transcriptomics Identify Thrombospondin‐2 as a Biomarker for NASH and Advanced Liver Fibrosis

Kazuhiro Kozumi, Takahiro Kodama, Hiroki Murai et al. · Hepatology · 2021 · 176 citations · Full text

Life Sciences, Molecular Biology, Pathology +17